Chemistry for peptide and protein PEGylation

被引:1280
作者
Roberts, MJ [1 ]
Bentley, MD [1 ]
Harris, JM [1 ]
机构
[1] Shearwater Corp, Huntsville, AL 35806 USA
关键词
PEGylation; PEG-protein; PEG conjugation; PEG chemistry;
D O I
10.1016/S0169-409X(02)00022-4
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Poly(ethylene glycol) (PEG) is a highly investigated polymer for the covalent modification of biological macromolecules and surfaces for many pharmaceutical and biotechnical applications. In the modification of biological macromolecules, peptides and proteins are of extreme importance, Reasons for PEGylation (i.e. the covalent attachment of PEG) of peptides and proteins are numerous and include shielding of antigenic and immunogenic epitopes, shielding receptor-mediated uptake by the reticuloendothelial system (RES), and preventing recognition and degradation by proteolytic enzymes. PEG conjugation also increases the apparent size of the polypeptide, thus reducing the renal filtration and altering biodistribution. An important aspect of PEGylation is the incorporation of various PEG functional groups that are used to attach the PEG to the peptide or protein. In this paper, we review PEG chemistry and methods of preparation with a particular focus on new (second-generation) PEG derivatives, reversible conjugation and PEG structures. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:459 / 476
页数:18
相关论文
共 68 条
  • [1] ABUCHOWSKI A, 1977, J BIOL CHEM, V252, P3582
  • [2] ABUCHOWSKI A, 1977, J BIOL CHEM, V252, P3578
  • [3] ABUCHOWSKI A, 1984, CANCER BIOCHEM BIOPH, V7, P175
  • [4] Selective synthesis of heterobifunctional poly(ethylene glycol) derivatives containing both mercapto and acetal terminals
    Akiyama, Y
    Otsuka, H
    Nagasaki, Y
    Kato, M
    Kataoka, K
    [J]. BIOCONJUGATE CHEMISTRY, 2000, 11 (06) : 947 - 950
  • [5] Algranati NE, 1999, HEPATOLOGY, V30, p190A
  • [6] Arnold F.H., 1994, US Patent, Patent No. [5,283,339, 5283339]
  • [7] Rational design of a potent, long-lasting form of interferon:: A 40 kDa branched polyethylene glycol-conjugated interferon α-2a for the treatment of hepatitis C
    Bailon, P
    Palleroni, A
    Schaffer, CA
    Spence, CL
    Fung, WJ
    Porter, JE
    Ehrlich, GK
    Pan, W
    Xu, ZX
    Modi, MW
    Farid, A
    Berthold, W
    [J]. BIOCONJUGATE CHEMISTRY, 2001, 12 (02) : 195 - 202
  • [8] A NEW PROCEDURE FOR THE SYNTHESIS OF POLYETHYLENE GLYCOL-PROTEIN ADDUCTS - EFFECTS ON FUNCTION, RECEPTOR RECOGNITION, AND CLEARANCE OF SUPEROXIDE-DISMUTASE, LACTOFERRIN, AND ALPHA-2-MACROGLOBULIN
    BEAUCHAMP, CO
    GONIAS, SL
    MENAPACE, DP
    PIZZO, SV
    [J]. ANALYTICAL BIOCHEMISTRY, 1983, 131 (01) : 25 - 33
  • [9] Bentley M. D., 1999, Patent No. [U.S. 5990237, 5990237, 5,990,237]
  • [10] Bentley M.D., 2001, Patent No. [WO 126692A1, 126692]